Is HUBV or MRK a better dividend investment in 2026?

HUBV currently yields 1818.18% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: HUBV offers higher current income.

What is the dividend yield difference between HUBV and MRK?

HUBV has a forward dividend yield of 1818.18% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 1814.93 percentage points.

Home › Compare › HUBV vs MRK

HUBV vs MRK: Dividend Comparison 2026

HUBV yields 1818.18% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 HUBV wins by $4103414683.81M in total portfolio value

INVESTMENT

TIME HORIZON10 years

HUBV

● Live price

1818.18%

Share price

$0.11

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4103414683.84M

Annual income

$3,702,796,788,756,407.00

Full HUBV calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — HUBV vs MRK

📍 HUBV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	HUBV	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, HUBV + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

HUBV pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HUBV

Annual income on $10K today (after 15% tax)

$154,545.45/yr

After 10yr DRIP, annual income (after tax)

$3,147,377,270,442,946.00/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, HUBV beats the other by $3,147,377,270,442,138.50/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HUBV + MRK for your $10,000?

HUBV: 50%MRK: 50%

100% MRK50/50100% HUBV

Portfolio after 10yr

$2051707341.93M

Annual income

$1,851,398,394,378,678.80/yr

Blended yield

90.24%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

HUBV

No analyst data

Altman Z

-117.6

Piotroski

1/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HUBV buys

MRK buys

No recent congressional trades found for HUBV or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricHUBVMRK

Forward yield	1818.18% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$4103414683.84M ✓	$30.7K
Annual income after 10y	$3,702,796,788,756,407.00 ✓	$950.29
Total dividends collected	$4074760433.31M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: HUBV vs MRK ($10,000, DRIP)

Year	HUBV Portfolio	HUBV Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$192,518	$181,818.18	$11,192	$351.54	+$181.3K → HUBV
2	$3,477,331	$3,271,336.99	$12,524	$392.70	+$3.46M → HUBV
3	$58,943,217	$55,222,471.89	$14,015	$438.65	+$58.93M → HUBV
4	$937,891,469	$874,822,227.57	$15,682	$489.96	+$937.88M → HUBV
5	$14,012,869,532	$13,009,325,660.38	$17,547	$547.23	+$14012.85M → HUBV
6	$196,647,994,247	$181,654,223,846.76	$19,632	$611.16	+$196647.97M → HUBV
7	$2,592,865,386,485	$2,382,452,032,641.56	$21,963	$682.53	+$2592865.36M → HUBV
8	$32,132,661,421,271	$29,358,295,457,731.54	$24,571	$762.18	+$32132661.40M → HUBV
9	$374,409,247,740,494	$340,027,300,019,734.44	$27,486	$851.08	+$374409247.71M → HUBV
10	$4,103,414,683,838,736	$3,702,796,788,756,407.00	$30,745	$950.29	+$4103414683.81M → HUBV

HUBV vs MRK: Complete Analysis 2026

HUBV — Stock

Hubb Ventures Inc. engages in the development and operation of IP application services for micro, small, and medium enterprise companies. It is also involved in the implementation of innovative agricultural models and products, which promotes entrepreneurship and collaboration within communities. In addition, the company provides and operates website development, digital marketing, advertising, and custom software. Hubb Ventures Inc. is based in Miami, Florida.

Full HUBV Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this HUBV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HUBV vs SCHD HUBV vs JEPI HUBV vs O HUBV vs KO HUBV vs MAIN HUBV vs JNJ HUBV vs ABBV HUBV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.